OVERVIEW

A virtual Experts Knowledge Share on the topic of ‘Optimising the management of multiple myeloma in the early relapsed/refractory setting’ with Scientific Committee Assoc. Prof. Karthik Ramasamy (UK), Prof. Aurore Perrot (France), Prof. Hermann Einsele (Germany) and Assoc. Prof. Joshua Richter (USA)

Topics of conversation include:

1. Challenges of optimising treatment for early relapsed/refractory multiple myeloma (RRMM) in the era of multiple novel therapies
2. Current treatments for early RRMM: Linking mechanism of action to efficacy
3. Best practices in combining and sequencing therapies for optimal outcomes in RRMM
4. Insights from clinical practice on how to manage tolerability and safety
5. Case studies and country-specific discussions (France, Germany/Austria and UK; held in breakout rooms in local language).

Please note that this meeting is only for HCPs practising in France, Germany, Austria and the UK.

This event is in collaboration with LYMPHOMA & MYELOMA CONNECT, an international group of experts in the field of hematological malignancies.

You will also have the opportunity to contribute to the discussion on this important topic. An honorarium of 100 EUROS is offered to HCPs for active participation and for completing the pre-meeting survey.

In registering for this meeting you are joining the COR2ED community. We will keep you informed of future meetings and programmes of interest.

Please submit your patient case study/questions for the faculty to selina.gill@cor2ed.com by 19th April 2024.

For more information please visit the official event page.